Extractables and Leachables (E&L) Testing

Introduction: Nitrosamine leachables in blister packaging have become one of the most closely scrutinized contamination pathways in oral solid dosage […]

Introduction Extractables & Leachables (E&L) Testing for Biosimilar Drug Development is a highly specialized, risk-based analytical approach developed to detect,

Introduction Obtain regulatory approval for IND, NDA, and BLA submissions with the support of professional Extractables & Leachables (E&L) Consulting

Introduction Extractables & Leachables (E&L) Testing for Veterinary Drug Products is an essential safety and regulatory requirement designed to ensure

Introduction Extractables & Leachables (E&L) Testing for Auto-Injectors involves the specialized chemical characterization and surveillance of substances that migrate from

Advanced Extractables & Leachables Testing for Ophthalmic Drug Products Evaluating extractables and leachables in ophthalmic formulations demands a detailed understanding

Introduction: Method validation for extractables and leachables testing is a regulatory non-negotiable — without a fully documented, ICH Q2(R2)-compliant validation

Introduction How Does a Comprehensive E&L Program Mitigate Risk in Prefilled Syringe Development? A comprehensive Extractables & Leachables (E&L) program

Regulatory Mechanisms Driving the Overlap of Elemental Leachables and ICH Q3D The principal intersection between elemental leachables and the toxicological

Introduction to Extractables and Leachables Thresholds in Impurity Control Extractables and leachables thresholds are scientifically established safety limits used to